# Liver Lipodystrophy in Barraquer–Simons Syndrome: How Much Should We Worry About?

## TL;DR

This paper discusses a case of liver lipodystrophy in a patient with Barraquer–Simons Syndrome, highlighting the importance of early diagnosis to prevent severe liver complications.

## Contribution

The paper emphasizes the diagnostic challenges and potential severity of liver lipodystrophy in Barraquer–Simons Syndrome.

## Key findings

- Liver lipodystrophy in Barraquer–Simons Syndrome can present with steatosis and multi-nodular lesions.
- Early diagnosis of liver disease is crucial to prevent severe outcomes in affected patients.
- Liver complications are a major cause of mortality in Barraquer–Simons Syndrome.

## Abstract

Lipodystrophy is a rare group of metabolic disorders characterized by the abnormal distribution of body fat, which can lead to various metabolic complications due to the body’s inability to adequately process carbohydrates and fat. We report the case of a female, aged 53 years, who was admitted as an outpatient for progressive weight loss of the upper part of the body (face, neck, arms, and chest), dyspeptic complaints, fatigue, mild insomnia, and anxious behavior. Her medical history was characterized by the presence of dyslipidemia, hypertension, and a minor stroke episode. However, she denied any family-relevant medical history. Although the clinical perspective suggested a possible late onset of partial acquired lipodystrophy, due to the imaging exam that revealed an enlarged liver with inhomogeneous structure with multiple nodular lesions, scattered over both lobes, a lot of lab work-ups and complementary studies were performed. Eventually, a liver biopsy was performed by a laparoscopic approach during cholecystectomy, the histology consistent with metabolic disease-associated steatohepatitis (MASH). In conclusion, given their heterogeneity and rarity, lipodystrophies may be either overlooked or misdiagnosed for other entities. Barraquer–Simons syndrome (BSS) may be associated with liver disease, including cirrhosis and liver failure. Liver lipodystrophy in BSS may sometimes feature steatosis with a focal, multi-nodular aspect, multiplying the diagnostic burden. Liver lipodystrophy may manifest as asymptomatic fat accumulation but may progress to severe conditions, representing one of the major causes of mortality in BSS, apart from the cardio-vascular comorbidities. Given the potential of severe outcomes, it is mandatory to correctly assess the stage of liver disease since the first diagnosis.